Senseonics Holdings, Inc.

NASDAQ:SENS

Medical - Devices

Healthcare
$9.74 -1.27%

-$0.09 today

Market cap
$533.56M
Beta
0.97
P/E (TTM)
-3.5
EPS (TTM)
-$1.90
52W Low $4.79High $12.58

Volume 0.87M

Average 0.71M

SENS Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Senseonics Holdings, Inc.NASDAQ: SENS

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development growth accelerates

Q1 FY2026 research & development of $8.61M rose 18.0% year over year, ahead of the -13.4% change in trailing-twelve-month research & development. Sequentially, it fell 2.4% from the prior quarter. Over 3 fiscal years it compounded at -7.3% a year.

Context

  • Research & development amounted to 89.6% of revenue in FY2025, down 93.5 pp from a year earlier.
  • Research & development increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +18.0% holds above the trailing-twelve-month pace of -13.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$8.61M-2.4% QoQ
Last fiscal yearDec 2025
$31.59M-23.2% YoY
LTMMar 2026
$32.9M-13.4% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+18.0%——
1 year-23.2%——
3-year CAGR-7.3%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
31.59M USD
Year-over-year change
-23.2%
4-year CAGR
+3.8%

Research & Development vs competitors

How SENS compares with its peers on the latest reported figures

  • SENS's LTM Mar 2026 research & development of $32.9M is the lowest of the 6 companies compared; the peer median is $345.9M.
  • Its year-over-year change of -13.4% is the 4th highest of 5, against a peer median of +19.5%.
  • Research & development amounts to 80.8% of revenue for SENS, versus a peer median of 13.6%.
SENS Competitors Peer median
Research & Development for SENS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DXCMDexCom, Inc.LTM Jun 2026$604M +6.3%+7.4%12.2%
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$439M —+1.5%13.6%
PODDInsulet CorporationLTM Jun 2026$345.9M +39.2%+18.7%11.3%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$188.1M -32.4%+0.9%18.3%
BBNXBeta Bionics, Inc.LTM Mar 2026$37.56M +32.7%+3.4%34.1%
SENSSenseonics Holdings, Inc.LTM Mar 2026$32.9M -13.4%-7.3%80.8%
Peer median (excluding SENS) $345.9M+19.5%+3.4%13.6%

Competitors are the stored peer set for SENS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.68M16.39M22.39M22.47M35.26M
Cost of Revenue14.49M13.66M19.3M21.94M19.49M
Gross Profit(811K)2.73M3.09M533K15.76M
Gross Margin-5.9%16.6%13.8%2.4%44.7%
Research & Development27.22M39.72M48.75M41.14M31.59M
Selling, General & Admin29.15M31.63M29.94M34.23M52.51M
Operating Expenses56.37M71.35M78.69M75.38M84.1M
Depreciation & Amortization1.24M985K1.28M1.48M1.51M
EBITDA(284.52M)161.81M(48.01M)(68.7M)(62.65M)
EBITDA Margin-2080.5%987.3%-214.4%-305.7%-177.7%
Operating Income(57.18M)(68.63M)(75.6M)(74.84M)(68.34M)
Operating Margin-418.1%-418.7%-337.7%-333.0%-193.8%
Interest Income243K1.82M5.36M4.5M4.2M
Interest Expense16.72M18.7M11.11M8.44M4.95M
Other Income / Expenses(245.29M)210.75M15.21M(3.77M)(776K)
Income Before Tax(302.47M)142.12M(60.39M)(78.62M)(69.11M)
Pre-Tax Margin-2211.9%867.2%-269.7%-349.8%-196.0%
Income Tax Expense00000
Net Income(302.47M)142.12M(60.39M)(78.62M)(69.11M)
Net Margin-2211.9%867.2%-269.7%-349.8%-196.0%
EPS (Basic)(14.40)6.07(2.20)(2.50)(1.66)
EPS (Diluted)(14.40)(2.17)(2.20)(2.50)(1.66)
Weighted Avg Shares21.12M23.4M28.4M31.49M41.73M
Weighted Avg Shares (Diluted)21.12M30.91M28.4M31.49M41.73M

Senseonics Holdings, Inc.

NASDAQ:SENS

Intrinsic Alpha fair value

Locked

Current Price

$9.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.